M. Fridkin

发表

A β-hairpin structure in a 13-mer peptide that binds α-bungarotoxin with high affinity and neutralizes its toxicity

E. Katchalski‐Katzir, M. Balass, S. Fuchs, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Turning low-molecular-weight drugs into prolonged acting prodrugs by reversible pegylation: a study with gentamicin.

Y. Shechter, M. Fridkin, Y. Marcus, 2008, Journal of medicinal chemistry.

Production and characterization of an antiserum to synthetic gonadotropin-releasing hormone.

M. Wilchek, U. Zor, M. Fridkin, 1973, Biochemical and biophysical research communications.

Degradation of gonadotropin-releasing hormones in the gilthead seabream, Sparus aurata. I. Cleavage of native salmon GnRH and mammalian LHRH in the pituitary.

Y. Zohar, M. Fridkin, A. Goren, 1990, General and comparative endocrinology.

Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability

I. Gozes, M. Gobbo, M. Fridkin, 2008, Journal of peptide science : an official publication of the European Peptide Society.

Novel extended and branched N-terminal analogs of VIP

I. Gozes, M. Fridkin, D. Dangoor, 2006, Regulatory Peptides.

(Stearyl, Norleucine17)VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells.

T. Moody, I. Gozes, M. Fridkin, 1997, Life sciences.

Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.

E. Mendelson, I. Shalit, M. Fridkin, 2009, International journal of peptide and protein research.

Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin

S. Shaltiel, M. Fridkin, M. Fridkin, 1993, FEBS letters.

Tuftsin–phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model

I. Barshack, Y. Shoenfeld, N. Bragazzi, 2018, Clinical and experimental immunology.

Adhesion of human platelets to serum amyloid A.

M. Fridkin, S. Urieli-Shoval, R. Linke, 2002, Blood.

Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils.

M. Fridkin, S. Urieli-Shoval, Y. Matzner, 1998, The Journal of laboratory and clinical medicine.

Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.

I. Gozes, M. Fridkin, M. Bodner, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Enzymic degradation of luteinizing hormone-releasing hormone (LH-RH) by hypothalamic tissue.

T. Baram, M. Fridkin, Y. Koch, 1974, Biochemical and biophysical research communications.

Suppression of gonadotropin secretion and prevention of ovulation in the rat by antiserum to synthetic gonadotropin-releasing hormone.

U. Zor, M. Fridkin, H. R. Lindner, 1973, Biochemical and biophysical research communications.

Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas.

O. Mandelboim, E. Vadai, M. Fridkin, 1997, Journal of immunology.

Angiotensin 1-7 as Means to Prevent the Metabolic Syndrome

I. Biton, G. Shefer, D. Benayahu, 2013, Diabetes.

NAP, a Femtomolar-Acting Peptide, Protects the Brain Against Ischemic Injury by Reducing Apoptotic Death

I. Gozes, H. Ovadia, D. Brenneman, 2002, Stroke.

Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.

P. Gressens, I. Gozes, D. Brenneman, 1994, The Journal of clinical investigation.

Structure-function studies of amphiphilic antibacterial peptides.

D. Desiderio, J. Metzger, I. Shalit, 1993, Journal of medicinal chemistry.

Tumor-associated antigen peptides as anti-metastatic vaccines

O. Mandelboim, E. Vadai, M. Fridkin, 1998, Letters in Peptide Science.

The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis.

Y. Shoenfeld, M. Blank, L. Cimino, 2019, Journal of autoimmunity.

Potentiating vanadium-evoked glucose metabolism by novel hydroxamate derivatives

Y. Shechter, I. Goldwaser, M. Fridkin, 2002, Letters in Peptide Science.

L-Glutamic acid gamma-monohydroxamate. A potentiator of vanadium-evoked glucose metabolism in vitro and in vivo.

J. Li, Y. Shechter, M. Armoni, 1999, The Journal of biological chemistry.

Binding of human serum amyloid P component (hSAP) to human neutrophils.

M. Pras, M. Pontet, M. Fridkin, 1994, European journal of biochemistry.

(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines.

T. Moody, I. Gozes, D. Brenneman, 1999, Life sciences.

Polymyxin B and Related Cyclic Peptides Facilitate Leanness and Reduce Fat Mass and Triglyceride Content in Ageing Rats: Potential Prototype Drugs Against Obesity

S. Amir, Y. Shechter, B. Sela, 2006, International Journal of Peptide Research and Therapeutics.

Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.

T. Moody, M. Birrer, I. Gozes, 1996, Cancer research.

Combined Local Blood–Brain Barrier Opening and Systemic Methotrexate for the Treatment of Brain Tumors

Y. Mardor, D. Last, D. Guez, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

M. Eisenstein, O. Mandelboim, M. Fridkin, 1997, Nature.

Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice.

F. Lemonnier, B. Tirosh, M. Fridkin, 2002, The Journal of clinical investigation.

Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion.

D. Metcalfe, R. Hershkoviz, O. Lider, 1997, The American journal of physiology.

Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.

F. Lemonnier, B. Tirosh, S. Pascolo, 2000, International journal of cancer.

Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination.

N. Vaĭsman, B. Tirosh, E. Vadai, 1999, Immunology letters.

Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites

E. Rajnavölgyi, P. Gogolák, M. Fridkin, 1997, European journal of immunology.

mechanism to enhance glucose metabolism Vanadate restores glucose 6-phosphate in diabetic rats: a

Y. Shechter, I. Goldwaser, M. Fridkin, 2016 .

Engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions.

Y. Shechter, M. Fridkin, M. Fridkin, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Albumin-insulin conjugate releasing insulin slowly under physiological conditions: a new concept for long-acting insulin.

Y. Shechter, M. Fridkin, S. Rubinraut, 2005, Bioconjugate chemistry.

Reversible PEGylation of peptide YY3‐36 prolongs its inhibition of food intake in mice

Y. Shechter, M. Fridkin, M. Rubinstein, 2005, FEBS letters.

Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1.

M. D. De Wolf, M. Fridkin, L. Kohn, 1981, The Journal of biological chemistry.

Sequential degradation of the neuropeptide gonadotropin‐releasing hormone by the 20 S granulosa cell proteasomes

W. Baumeister, M. Fridkin, Y. Koch, 1994, FEBS letters.

β2-Glycoprotein-I based peptide regulate endothelial-cells tissue-factor expression via negative regulation of pGSK3β expression and reduces experimental-antiphospholipid-syndrome.

E. Katchalski‐Katzir, M. Eisenstein, Y. Shoenfeld, 2011, Journal of autoimmunity.

The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses.

D. Robinson, M. Fridkin, Z. Nevo, 2003, Experimental and molecular pathology.

Prolonging the Action of Protein and Peptide Drugs by a Novel Approach of Reversible Polyethylene Glycol Modification*

Y. Shechter, M. Fridkin, M. Mironchik, 2004, Journal of Biological Chemistry.

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

P. Gressens, I. Gozes, D. Brenneman, 1993, Nature.

Binding of C‐reactive protein to human neutrophils

M. Pontet, M. Fridkin, M. Fridkin, 1987, FEBS letters.

Serum amyloid A complexed with extracellular matrix induces the secretion of tumor necrosis factor-α by human T-lymphocytes

M. Pras, L. Cahalon, O. Lider, 1998, Letters in Peptide Science.

Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.

I. Gozes, D. Brenneman, M. Fridkin, 1998, The Journal of pharmacology and experimental therapeutics.

Cell Function-Associated Antigen Mediator of the Inhibitory Action of the Mast-Phosphatase Is the Main ′ Polyphosphate 5 SH 2 Domain-Containing Inositol

J. Abramson, M. Fridkin, R. Xu, 2001 .

Novel naphthoquinonyl derivatives: Potential structural components for the synthesis of cytotoxic peptides

M. Fridkin, L. Weiner, S. Rahimipour, 1996, Letters in Peptide Science.

Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides.

E. Katchalski‐Katzir, Y. Shoenfeld, M. Blank, 1999, Proceedings of the National Academy of Sciences of the United States of America.

New Technologies to Prolong Life-time of Peptide and Protein Drugs In vivo

B. Mester, Y. Shechter, M. Fridkin, 2007, International Journal of Peptide Research and Therapeutics.

IL-2 induces T cell adherence to extracellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase.

A. Ariel, A. Avron, R. Hershkoviz, 1998, Journal of immunology.

Preventive Treatment of Alzheimer’s Disease

I. Gozes, A. Bardea, D. Brenneman, 1998 .

Archaebacterial and eukaryotic proteasomes prefer different sites in cleaving gonadotropin-releasing hormone

W. Baumeister, P. Zwickl, M. Fridkin, 1995, The Journal of Biological Chemistry.

Analysis of ligand binding to the synthetic dodecapeptide 185-196 of the acetylcholine receptor alpha subunit.

S. Fuchs, M. Fridkin, D. Barchan, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Effect of serum amyloid A, HDL-apolipoprotein, on endothelial cell proliferation. Implication of an enigmatic protein to atherosclerosis.

M. Fridkin, A. Knyszynski, L. Preciado-Patt, 1996, Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity.

Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor

I. Gozes, M. Fridkin, M. Bodner, 1986, Peptides.

Poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid). I. Synthesis

E. Katchalski‐Katzir, M. Fridkin, H. Goren, 1977 .

Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis

M. Sela, E. Mozes, I. Wirguin, 1998, Journal of Neuroimmunology.

Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: use of overlapping peptide sequences to identify a unique inhibitor.

M. Fridkin, E. J. Yavin, 2009, Journal of Peptide Research.

Leukocyte Elastase and Migration by IL-2 Peptides Generated by Adherence Extracellular Matrix: Inhibition of IL-2 Induces T Cell Adherence to

A. Ariel, A. Avron, R. Hershkoviz, 1998 .

Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G.

D. Desiderio, M. Fridkin, E. J. Yavin, 2009, International journal of peptide and protein research.

Immune Response of SLE Patients to Peptides Based on the Complementarity Determining Regions of a Pathogenic Anti-DNA Monoclonal Antibody

A. Waisman, E. Mozes, M. Fridkin, 2000, Journal of Clinical Immunology.

A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs.

H. Zinger, E. Mozes, M. Fridkin, 2000, Cellular immunology.

The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide.

M. Fridkin, I. Ofek, S. Cohen, 2000, Biochemistry.

Antigenicity and Immunogenicity of an Intracellular Delivery System of Major Histocompatibility Complex Class I Epitopes That Bypasses Proteasome Processing

F. Lemonnier, B. Tirosh, E. Vadai, 2000, Journal of immunotherapy.

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.

M. Sela, E. Mozes, I. Wirguin, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis and biological activity of [L‐hydroxyproline]3‐tuftsin analogue and its α‐ or β‐O‐D‐glucosylated derivatives

M. Fridkin, E. Tzehoval, R. Rocchi, 2009 .

Tuftsin Receptors a

S. Segal, P. Gottlieb, M. Fridkin, 1983 .

Structure-function relationship in the interaction of mastoparan analogs with neutrophil NADPH oxidase.

M. Fridkin, F. Wientjes, I. Aviram, 2001, Biochemical Pharmacology.

C‐reactive protein decreases protein phosphorylation in stimulated human neutrophils

M. Pontet, R. Gennaro, M. Fridkin, 1988, FEBS letters.

Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues.

M. D. De Wolf, M. Fridkin, L. Kohn, 1981, The Journal of biological chemistry.

Tuftsin, Thr-Lys-Pro-Arg

P. Gottlieb, M. Fridkin, 1981, Molecular and Cellular Biochemistry.

Pneumococcal Capsular Polysaccharide Is Immunogenic When Present on the Surface of Macrophages and Dendritic Cells: TLR4 Signaling Induced by a Conjugate Vaccine or by Lipopolysaccharide Is Conducive1

Steffen Jung, M. Pevsner-Fischer, I. Cohen, 2008, Journal of Immunology.

This information is current as by Lipopolysaccharide Is Conducive Signaling Induced by a Conjugate Vaccine or Macrophages and Dendritic Cells : TLR 4 ofImmunogenic When Present on the Surface Pneumococcal Capsular Polysaccharide Is Eisenbach

Steffen Jung, M. Pevsner-Fischer, I. Cohen, 2008 .

Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction.

M. Caruthers, H. Khorana, A. Kumar, 1976, The Journal of biological chemistry.

Gonadotropin-releasing hormone in milk.

T. Baram, M. Fridkin, E. Hazum, 1977, Science.

A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells.

E. Mozes, M. Fridkin, E. Eilat, 2000, Immunobiology.

VIP and the potent analog, stearyl‐Nle17‐VIP, induce proliferation of keratinocytes

I. Gozes, M. Fridkin, M. Fridkin, 2000, FEBS letters.

Inhibition of human neuroblastoma growth by a specific VIP antagonist

I. Gozes, G. Lilling, D. Brenneman, 2007, Journal of Molecular Neuroscience.

Vasoactive intestinal peptide: a growth promotor in neuroblastoma cells

I. Gozes, G. Lilling, M. Fridkin, 1993, Brain Research.

Facile thiolytic removal of the o-nitrophenylsulphenyl amino-protecting group.

M. Fridkin, A. Warshawsky, M. Stern, 2009, International journal of peptide and protein research.

Altered Peptide Ligands of a Myasthenogenic Epitope as Modulators of Specific T‐Cell Responses

M. Sela, E. Mozes, M. Fridkin, 1996, Scandinavian journal of immunology.

Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.

M. Sela, E. Mozes, O. Abramsky, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in an in Vitro Model of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins*

Y. Shechter, M. Schnaider-Beeri, M. Fridkin, 2012, The Journal of Biological Chemistry.

The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.

Y. Shoenfeld, S. Goldman, E. Shalev, 2007, International immunology.

A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo.

Xiaowei Liu, Y. Shoenfeld, M. Blank, 2004, Journal of autoimmunity.

Immunoreactive and biologically active somatostatin in human and sheep milk.

R. Millar, M. Fridkin, Y. Koch, 1985, European journal of biochemistry.

A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

I. Gozes, M. Fridkin, 1992, The Journal of clinical investigation.

The effect of Tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes.

M. Fridkin, V. Zakuth, Z. Spirer, 1975, The Journal of clinical investigation.

Thiolysis of Nim-2,4-dinitrophenyl-histidine peptides with 2-mercaptoethanol. An explannation for the pH optimum.

M. Fridkin, H. Goren, 2009, International journal of peptide and protein research.

Poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid). II. Catalysis of p‐nitrophenyl acetate hydrolysis

M. Fridkin, H. Goren, T. Fletcher, 1978 .

Synthesis and catalytic properties of the heptapeptide L-seryl-L-prolyl-L-cysteinyl-L-steryl-alpha-L-glutamyl-L-threonyl-L-tyrosine.

M. Fridkin, H. Goren, 1974, European journal of biochemistry.

Detection of peptide active esters by thin-layer chromatography.

M. Fridkin, H. Goren, 1970, Analytical biochemistry.

Nonaqueous titrimetric determination of active esters of amino acids and peptide derivatives.

M. Wilchek, M. Fridkin, A. Patchornik, 1970, Analytical chemistry.

VIP receptor antagonists and chemotherapeutic drugs inhibit the growth of breast cancer cells

T. Moody, I. Gozes, D. Chan, 2001, Breast Cancer Research and Treatment.

ACUTE LETHAL TOXICITY IN MICE

Z. Fuks, L. Weiss, R. Catane, 2006 .

Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes.

P. Gottlieb, M. Fridkin, V. Zakuth, 1978, Biochemical and biophysical research communications.

Enhancement of phagocytosis - a newly found activity of substance P residing in its N-terminal tetrapeptide sequence.

R. Goldman, P. Gottlieb, M. Fridkin, 1980, Biochemical and biophysical research communications.

Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.

Y. Shoenfeld, M. Blank, M. Fridkin, 2015, Journal of autoimmunity.

VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress

B. Solomon, I. Gozes, D. Brenneman, 2000, Journal of Molecular Neuroscience.

Proteolysis of human C-reactive protein by neutrophil-derived lysosomal enzymes generates peptides which modulate neutrophil function: Implication to the anti-inflammatory mechanism

M. Pontet, M. Fridkin, E. Shephard, 1995, Letters in Peptide Science.

Binding of human serum amyloid A (hSAA) and its high-density lipoprotein3 complex (hSAA-HDL3) to human neutrophils. Possible implication to the function of a protein of an unknown physiological role.

M. Pras, M. Fridkin, L. Preciado-Patt, 2009, International journal of peptide and protein research.

Characterization of neutrophil‐mediated degradation of human C‐reactive protein and identification of the protease

R. Anderson, M. Fridkin, E. Shephard, 1992, Clinical and experimental immunology.

Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.

G. Schreiber, Y. Shechter, M. Fridkin, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.

S. Dagan, M. Fridkin, E. Tzehoval, 2009, International journal of peptide and protein research.

Proteolysis of acute phase proteins: Implication to the anti-inflammatory response

M. Pras, M. Pontet, M. Fridkin, 1992 .

Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.

M. Fridkin, M. Fridkin, I. Ofek, 2000, Journal of medicinal chemistry.

Neuropeptide receptor transcripts are expressed in the rat clitoris and oscillate during the estrus cycle in the rat vagina

I. Gozes, M. Fridkin, D. Dangoor, 2005, Peptides.

Immunostimulation by an Ig derived tetrapeptide, tuftsin

S. Segal, M. Fridkin, E. Tzehoval, 1979, Springer Seminars in Immunopathology.

Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth

I. Gozes, D. Brenneman, M. Fridkin, 1999, Neuroscience.

The molecular and cellular basis of exostosis formation in hereditary multiple exostoses

H. Werner, D. Chan, K. Cheah, 2008, International journal of experimental pathology (Print).

Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.

S. Segal, M. Fridkin, E. Tzehoval, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Deoxyoligonucleotide synthesis using a new phosphate protecting group.

H. Khorana, M. Fridkin, K. Agarwal, 1973, Journal of the American Chemical Society.

From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP

Inbar Pilzer, I. Gozes, A. D. Spier, 2007, Journal of Molecular Neuroscience.

Human peritoneal macrophage activity is increased by tuftsin.

S. Segal, R. Levy, C. Chaimovitz, 1989, Immunology letters.

Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells.

R. Hershkoviz, O. Lider, M. Fridkin, 1996, Journal of immunology.

Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein.

R. Hershkoviz, O. Lider, M. Fridkin, 1994, European journal of biochemistry.

Receptor-mediated endocytosis of tuftsin by macrophage cells.

S. Segal, P. Gottlieb, M. Fridkin, 1984, Biochemical and biophysical research communications.

Monofunctional substrates of polynucleotide phosphorylase. The monoaddition of 2'(3')-O-isovaleryl-nucleoside diphosphate to an initiator oligonucleotide.

G. Kaufmann, U. Littauer, M. Fridkin, 1971, European journal of biochemistry.

Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.

M. Fridkin, V. Zakuth, Z. Spirer, 1977, Biochimica et biophysica acta.

Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides

Michael Feldman, O. Mandelboim, E. Vadai, 1995, Nature Medicine.

Hexapeptide and cyclic pentapeptide endothelin antagonists directly activate pituitary gonadotropin-releasing hormone receptors.

M. Fridkin, Y. Koch, N. Ben-Aroya, 2000, Molecular pharmacology.

Tuftsin induces tissue factor-like activity in human mononuclear cells and in monocytic cell lines.

R. Catane, M. Fridkin, A. Kornberg, 1990, Blood.

Tuftsin: its chemistry, biology, and clinical potential.

M. Fridkin, M. Fridkin, V. Najjar, 1989, Critical reviews in biochemistry and molecular biology.

Radioimmunoassay of the phagocytosis‐stimulating peptide tuftsin in normal and splenectomized subjects

M. Fridkin, V. Zakuth, Z. Spirer, 1977, European journal of immunology.

Rapid separation of synthetic oligonucleotide mixtures on aromatic cellulose derivatives.

H. Khorana, M. Fridkin, K. Agarwal, 1974, Methods in enzymology.

Use of trityl- and -naphthylcarbamoylcellulose derivatives in oligonucleotide synthesis.

H. Khorana, M. Fridkin, K. Agarwal, 1973, Biochemistry.

A photolabile protecting group for the phenolic hydroxyl function of tyrosine.

M. Fridkin, E. Hazum, A. Patchornik, 2009, International journal of peptide and protein research.

Thiolysis of O-2,4-dinitrophenyltyrosines. Spectrophotometric monitoring of the reaction and its use in peptide synthesis.

S. Shaltiel, M. Fridkin, M. Tauber-Finkelstein, 1977, Archives of biochemistry and biophysics.

Thiolysis of dinitrophenylimidazoles and its use during synthesis of histidine peptides.

S. Shaltiel, M. Fridkin, 1970, Biochemistry.

Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives.

P. Gressens, I. Gozes, P. Robberecht, 1999, The Journal of pharmacology and experimental therapeutics.

Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes

D. Gefel, Y. Shechter, I. Goldwaser, 2003 .

SYNTHESES AND POLYMERIZATION OF α-TRIMETHYLSILYL ACRYLIC MONOMERS

M. Fridkin, A. Zilkha, A. Ottolenghi, 1963 .

1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogs.

Y. Gaoni, M. Fridkin, E. Tzehoval, 1996, Journal of medicinal chemistry.

Insulin-like effects of vanadium: basic and clinical implications.

D. Gefel, Y. Shechter, I. Goldwaser, 2000, Journal of inorganic biochemistry.

The detection of peptide hydrazides on thin-layer chromatograms.

M. Fridkin, H. Goren, 1970, Journal of chromatography.

The Binding Site of Acetylcholine Receptor as Visualized in the X-Ray Structure of a Complex between α-Bungarotoxin and a Mimotope Peptide

Joel L. Sussman, Ephraim Katchalski-Katzir, August B. Smit, 2001, Neuron.

N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity

M. Fridkin, I. Ofek, H. Tsubery, 2001, Peptides.

New useful reagents for peptide synthesis. Insoluble active esters of polystyrene-bound 1-hydroxybenzotriazole.

M. Fridkin, A. Warshawsky, A. Patchornik, 1975, European journal of biochemistry.

A Synthesis of Cyclic Peptides Utilizing High Molecular Weight Carriers

E. Katchalski, M. Fridkin, A. Patchornik, 1965 .

Use of polymers as chemical reagents. II. Synthesis of bradykinin.

E. Katchalski, M. Fridkin, A. Patchornik, 1968, Journal of the American Chemical Society.

Use of Polymers as Chemical Reagents. I. Preparation of Peptides

E. Katchalski, M. Fridkin, A. Patchornik, 1966 .

Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators.

Y. Shechter, I. Goldwaser, M. Fridkin, 2000, Molecular pharmacology.

Luliberin analogues exhibiting a cytotoxic effect on tumor cells in vitro

M. Blank, M. Fridkin, S. Burov, 2006, Russian Journal of Bioorganic Chemistry.

Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbb protein

A. Ullrich, M. Waterfield, I. Lax, 1985, Cell.

A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes.

I. Gozes, A. Pinhasov, D. Brenneman, 2002, Life sciences.

Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.

I. Gozes, A. Bardea, R. Zamostiano, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The gene for the neuropeptide gonadotropin-releasing hormone is expressed in the mammary gland of lactating rats.

Y. Burstein, S. Tel-or, A. Palmon, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Newly designed modifier prolongs the action of short-lived peptides and proteins by allowing their binding to serum albumin.

Y. Shechter, M. Fridkin, K. Sasson, 2012, Bioconjugate chemistry.

Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.

P. Gressens, I. Gozes, P. Evrard, 1997, The Journal of clinical investigation.

A VIP hybrid antagonist: From developmental neurobiology to clinical applications

I. Gozes, D. Brenneman, M. Fridkin, 1995, Cellular and Molecular Neurobiology.

An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

T. Moody, I. Gozes, D. Brenneman, 1991, The Journal of pharmacology and experimental therapeutics.

Antibodies directed against phosphothreonine residues as potent tools for studying protein phosphorylation.

Y. Zick, M. Fridkin, D. Heffetz, 1989, European journal of biochemistry.

M. Fridkin, R. Buchta, E. Bondi, 2009, International journal of peptide and protein research.

Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun*

E. Muñoz-Elías, I. Gozes, M. Delgado, 1998, The Journal of Biological Chemistry.

Novel analogs of VIP with multiple C-terminal domains

I. Gozes, M. Fridkin, D. Dangoor, 2007, Peptides.

P Agonists and 1 Tissue and ity : Effects on ration , Sexual Biologic Clock "

T. Moody, O. Ashur-Fabian, I. Gozes, 2006 .

Intranasal Delivery of Bioactive Peptides or Peptide Analogues Enhances Spatial Memory and Protects Against Cholinergic Deficits

I. Gozes, A. Pinhasov, M. Fridkin, 2001 .

Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

O. Ashur-Fabian, I. Gozes, M. Fridkin, 1999, Proceedings of the National Academy of Sciences of the United States of America.

PACAP hybrid: a new PACAP receptor antagonist.

T. Moody, M. Birrer, I. Gozes, 1997, Life sciences.

Neuropeptides and Neuronal Survival: Neuroprotective Strategy for Alzheimer's Disease a

I. Gozes, A. Bardea, R. Zamostiano, 1997, Annals of the New York Academy of Sciences.

Development of VIP Agonists and Antagonists with Tissue and Receptor Specificity: Effects on Behavioral Maturation, Sexual Function, and the Biologic Clock a

T. Moody, O. Ashur-Fabian, I. Gozes, 1996, Annals of the New York Academy of Sciences.

A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes

I. Gozes, D. Brenneman, M. Fridkin, 1991, Brain Research.

Vasoactive intestinal peptide potentiates sexual behavior: Inhibition by novel antagonist

I. Gozes, D. Brenneman, M. Fridkin, 1989, Regulatory Peptides.

A new route to polyamino acids containing histidine.

S. Shaltiel, M. Fridkin, 1971, Archives of biochemistry and biophysics.

Generation of specific antiserum to thyrotropin releasing‐hormone and its use in a radioimmunoassay

T. Baram, M. Fridkin, Y. Koch, 1976, FEBS letters.

Use of Nim-t-Butyloxycarbonyl in the Synthesis of Poly-L-histidine

M. Fridkin, H. Goren, 1971 .

Poly(L‐leucyl‐L‐ornithyl‐L‐leucine) and its Guanidization Product: Synthesis and Antibacterial Activity

M. Fridkin, M. Fridkin, A. Frenkel, 1969, Biopolymers.

All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance

I. Shalit, M. Fridkin, R. Bessalle, 1990, FEBS letters.

Degradation of Luteinizing Hormone-Releasing Hormone by Rat Pituitary Plasma Membrane Associated Enzymes

S. Elkabes, M. Fridkin, Y. Koch, 1984 .

Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 5. Synthesis of the deoxyribopolynucleotide segments representing the nucleotide sequence 71-103.

M. Caruthers, H. Khorana, M. Fridkin, 1976, The Journal of biological chemistry.

Mediators of Cellular Immunity

S. Segal, M. Fridkin, E. Tzehoval, 1979 .

I. Gozes, D. Brenneman, M. Fridkin, 2000, Journal of Molecular Neuroscience.

Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

A. Tobar, Y. Shoenfeld, M. Blank, 2002, The Journal of clinical investigation.

Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretion.

B. Tartakovsky, S. Dagan, M. Fridkin, 1988, Journal of biological response modifiers.

Tuftsin and tuftsin conjugates potentiate immunogenic processes: effects and possible mechanisms.

S. Dagan, M. Fridkin, E. Tzehoval, 1987, Journal of biological response modifiers.

Augmentation of the antibacterial activity of magainin by positive-charge chain extension

I. Shalit, M. Fridkin, R. Bessalle, 1992, Antimicrobial Agents and Chemotherapy.

ANTINEOPLASTIC, IMMUNOGENIC AND OTHER EFFECTS OF THE TETRAPEPTIDE TUFTSIN: A NATURAL MACROPHAGE ACTIVATOR

M. Fridkin, V. Najjar, 1983 .

Introduction of the dansyl group into histidine and tyrosine residues in peptides and proteins.

M. Fridkin, R. Buchta, 1985, Biochemical and biophysical research communications.

Synthetic peptide approach to the analysis of kinase activities of avian EGF receptor and v-erbB protein.

A. Ullrich, M. Waterfield, I. Lax, 1985, Biochimie.

Mast cell adhesion to extracellular matrix: local effects of acute phase reactants.

R. Hershkoviz, O. Lider, M. Fridkin, 1997, International archives of allergy and immunology.

Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease.

I. Gozes, A. Bardea, M. Fridkin, 1997, Journal of neurobiology.

Structure activity relationship study of polymyxin B nonapeptide.

M. Fridkin, I. Ofek, S. Cohen, 2000, Advances in experimental medicine and biology.

Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamus

I. Gozes, M. Fridkin, Y. Koch, 2008, Journal of Molecular Neuroscience.

Estrogen regulation of vasoactive intestinal peptide mRNA in rat hypothalamus

I. Gozes, M. Fridkin, Y. Koch, 2008, Journal of Molecular Neuroscience.

The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope.

E. Mozes, E. Husebye, M. Fridkin, 2006, Endocrinology.

Tuftsin‐AZT conjugate: potential macrophage targeting for AIDS therapy

M. Fridkin, E. Tzehoval, R. Rocchi, 2005, Journal of peptide science : an official publication of the European Peptide Society.

Degradation of gonadotropin-releasing hormones in the gilthead seabream, Sparus aurata. II. Cleavage of native salmon GnRH, mammalian LHRH, and their analogs in the pituitary, kidney, and liver.

Y. Zohar, M. Fridkin, A. Goren, 1990, General and comparative endocrinology.

Comparative structure-activity studies on mammalian [Arg8] LH-RH and chicken [Gln8] LH-RH by fluorimetric titration.

M. Badminton, R. Millar, M. Fridkin, 1983, Biochemical and Biophysical Research Communications - BBRC.

Resistance to enzymic degradation of LH-RH analogues possessing increased biological activity.

T. Baram, M. Fridkin, M. Fridkin, 1977, Biochemical and biophysical research communications.

Synthesis of poly‐L‐asparagine and poly‐L‐glutamine

M. Fridkin, A. Patchornik, S. Ariely, 1969 .

Studies on the activity of phorbol myrystate acetate on the human polymorphonuclear leukocytes

M. Fridkin, V. Zakuth, Z. Spirer, 1979, Experientia.

Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice

O. Koren, Y. Shoenfeld, M. Blank, 2017, Front. Microbiol..

Synthesis of modified tuftsins containing monosaccharides or monosaccharide derivatives.

M. Gobbo, S. Dagan, M. Fridkin, 1987, International journal of peptide & protein research.

Antibodies to synthetic peptides as probes for the binding site on the alpha subunit of the acetylcholine receptor.

J. Gershoni, S. Fuchs, M. Fridkin, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.

M. Gobbo, S. Dagan, M. Fridkin, 1987, International journal of peptide and protein research.

Synthesis and biological activity of tuftsin and of [O = C Thr1]-tuftsin. A novel synthetic route to peptides containing N-terminal L -O = C Thr and L - O = C Ser residues.

M. Fridkin, V. Zakuth, Z. Spirer, 2009, International journal of peptide and protein research.

Synthetic Pathways to Tuftsin and Radioimmunoassay

P. Gottlieb, M. Fridkin, V. Zakuth, 1983 .

Use of Polymeric Reagents in the Synthesis of Linear and Cyclic Peptides

E. Katchalski, M. Fridkin, A. Patchornik, 1973 .

Modulation of human neutrophil function by C-reactive protein.

M. Pontet, M. Fridkin, B. Scaggiante, 1987, European journal of biochemistry.

Decreased tuftsin concentrations in patients who have undergone splenectomy.

M. Fridkin, V. Zakuth, Z. Spirer, 1977, British medical journal.

Toxicology and antitumor activity of tuftsin in mice. Abstr.

Z. Fuks, R. Catane, P. Gottlieb, 1981 .

Acquired Tuftsin Deficiency

M. Fridkin, R. Orda, V. Zakuth, 1983, Annals of the New York Academy of Sciences.

Tuftsin analogs for probing its specific receptor site on phagocytic cells.

P. Gottlieb, M. Fridkin, M. Fridkin, 1982, European journal of biochemistry.

Growth hormone releasing factor and somatostatin concentrations in the milk of lactating women

M. Fridkin, Y. Koch, H. Werner, 1988, European Journal of Pediatrics.

Luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in human and bovine milk.

M. Fridkin, M. Fridkin, Y. Koch, 2005, European journal of biochemistry.

‘1-8 interferon inducible gene family’: putative colon carcinoma-associated antigens

B. Tirosh, E. Vadai, M. Do, 2007, British Journal of Cancer.

Decreased serum tuftsin concentrations in sickle cell disease.

Y. Weisman, M. Fridkin, V. Zakuth, 1980, Archives of disease in childhood.

High levels of vasoactive intestinal peptide in human milk.

I. Gozes, J. Fahrenkrug, M. Fridkin, 1985, Biochemical and biophysical research communications.

Inhibition by tuftsin of Rauscher virus leukemia development in mice.

P. Gottlieb, M. Fridkin, A. Knyszynski, 1983, Journal of the National Cancer Institute.

CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

M. Eisenstein, O. Mandelboim, M. Fridkin, 1994, Nature.

Novel breast‐tumor‐associated MUC1‐derived peptides: Characterization in Db−/− × β2 microglobulin (β2m) null mice transgenic for a chimeric HLA‐A2.1/Db‐β2 microglobulin single chain

F. Lemonnier, B. Tirosh, S. Pascolo, 2000 .

Peptide synthesis by means of tert-butyloxycarbonylamino acid derivatives of poly(ethylene-co-N-hydroxymaleimide).

E. Katchalski, M. Fridkin, A. Patchornik, 1972, Biochemistry.

Studies on the enzymic degradation of luteinizing hormone releasing hormone by rat pituitary plasma membranes.

S. Elkabes, M. Fridkin, Y. Koch, 1981, Biochemical and biophysical research communications.

Reversible pegylation of insulin facilitates its prolonged action in vivo.

Y. Shechter, M. Fridkin, Y. Marcus, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Neopeptide Antibiotics That Function as Opsonins and Membrane-Permeabilizing Agents for Gram-Negative Bacteria

M. Fridkin, I. Ofek, H. Tsubery, 2005, Antimicrobial Agents and Chemotherapy.

Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization.

M. Eisenstein, M. Fridkin, I. Ofek, 2002, Molecular pharmacology.

Generation and use of antibodies to phosphothreonine.

Y. Zick, M. Fridkin, D. Heffetz, 1991, Methods in enzymology.

An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases.

C. Hampe, M. Fridkin, I Pecht, 2000, European journal of biochemistry.

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

T. Moody, I. Gozes, D. Brenneman, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Studies toward the biosynthesis of vasoactive intestinal peptide (VIP)

I. Gozes, M. Fridkin, M. Bodner, 1984, Peptides.

Detection of mRNAs containing regulatory peptide coding sequences using synthetic oligodeoxynucleotides

I. Gozes, M. Fridkin, M. Bodner, 1984, Journal of cellular biochemistry.

Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis

D. Kohavi, I. Gozes, Y. Gabet, 2021, Frontiers in Pharmacology.

The Binding Site of Acetylcholine Receptor

E. Katchalski‐Katzir, J. Sussman, M. Harel, 2003 .

The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure.

E. Katchalski‐Katzir, J. Sussman, M. Balass, 2003, Annals of the New York Academy of Sciences.

Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies

Andreas Radbruch, Y. Shoenfeld, M. Blank, 2000, Thrombosis and haemostasis.

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat

I. Gozes, D. Brenneman, M. Fridkin, 1991, Peptides.

Polymeric 2-mercaptopyridine and 2-mercapto-nitrobenzene derivatives. New reagents for peptide synthesis.

M. Fridkin, M. Stern, A. Warshawksy, 2009, International journal of peptide and protein research.

Spectral studies with histidyl-tryptophan peptides.

M. Shinitzky, M. Fridkin, 1969, European journal of biochemistry.

Structure-activity relationships of luliberin substituted at position 8.

M. Shinitzky, M. Fridkin, E. Hazum, 1976, Biochimica et biophysica acta.

Structural features of luliberin (luteinising hormone-releasing factor) inferred from fluorescence measurements.

M. Shinitzky, M. Fridkin, 1976, Biochimica et biophysica acta.

On the function of arginine in luteinizing hormone‐releasing hormone

R. Meidan, M. Fridkin, E. Hazum, 1977, FEBS letters.

Mercuration of tryptophan in luteinizing hormone-releasing hormone.

R. Meidan, M. Fridkin, E. Hazum, 1978, The International journal of biochemistry.

Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations

Y. Shechter, M. Fridkin, I. Cooper, 2016, PloS one.

Establishing the principle of reversibility in peptide/protein and small-molecule therapy.

Y. Shechter, M. Fridkin, Y. Marcus, 2012, Therapeutic delivery.

Prolonging the half-life of human interferon-α2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-α2

Gideon Schreiber, G. Schreiber, Y. Shechter, 2001 .

A novel approach for a water-soluble long-acting insulin prodrug: design, preparation, and analysis of [(2-sulfo)-9-fluorenylmethoxycarbonyl](3)-insulin.

Y. Shechter, I. Goldwaser, M. Fridkin, 2000, Journal of medicinal chemistry.

New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin.

Y. Shechter, M. Fridkin, E. Gershonov, 1999, Diabetes.

Conformational changes of poly(L‐histidyl‐L‐alanyl‐α‐L‐glutamic acid) in solution. Transition pathways and conformational intermediates

E. Katchalski‐Katzir, N. Lotan, M. Fridkin, 1979 .

Protection Against Developmental Deficiencies by a Lipophilic VIP Analogue

I. Gozes, A. Bardea, M. Fridkin, 1998, Neurochemical Research.

Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors.

I. Gozes, G. Lilling, I. Ashkenazi, 1995, The Journal of pharmacology and experimental therapeutics.

Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatment.

I. Gozes, M. Fridkin, S. Rubinraut, 1994, Endocrinology.

Novel therapeutic compound tuftsin–phosphorylcholine attenuates collagen‐induced arthritis

I. Barshack, Y. Shoenfeld, M. Fridkin, 2016, Clinical and experimental immunology.

Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.

Y. Shoenfeld, M. Blank, M. Fridkin, 2015, Journal of autoimmunity.

3. The binding site for -bungarotoxin in the acetylcholine receptor: from synthetic peptides to solution and crystal structure

E. Katchalski‐Katzir, M. Harel, M. Balass, 2003 .

Design and synthesis of peptides that bind α-bungarotoxin with high affinity

E. Katchalski‐Katzir, M. Balass, S. Fuchs, 2001 .

Thiolysis of the 3-nitro-2-pyridinesulfenyl (Npys) protecting group. An approach towards a general deprotection scheme in peptide synthesis.

M. Fridkin, S. Rubinraut, O. Rosen, 1990, International journal of peptide and protein research.

Suspensions of pro-drug insulin greatly prolong normoglycemic patterns in diabetic rats.

Y. Shechter, M. Fridkin, H. Tsubery, 2003, Biochemical and biophysical research communications.

Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides.

H. Gewurz, F. D. de Beer, M. Fridkin, 1992, Molecular immunology.

Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis

M. Eisenstein, I. Barshack, Y. Shoenfeld, 2018, PloS one.

Peptides generated from C-reactive protein by a neutrophil membrane protease. Amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxis.

R. Anderson, F. D. de Beer, A. Strachan, 1990, Journal of immunology.

Delivery of neuropeptides from the periphery to the brain: studies with enkephalin.

Y. Shechter, E. Heldman, M. Fridkin, 2010, ACS chemical neuroscience.

[2-Sulfo-9-fluorenylmethoxycarbonyl]3-exendin-4-a long-acting glucose-lowering prodrug.

Y. Shechter, M. Fridkin, H. Tsubery, 2003, Biochemical and biophysical research communications.

A new approach for prolonging the half-life of peptides, proteins and low-molecular-weight drugs in vivo

B. Mester, Y. Shechter, I. Goldwaser, 2001 .

Degradation of gonadotropin‐releasing hormone by anterior pituitary enzymes

T. Baram, M. Fridkin, E. Hazum, 1981, FEBS letters.

Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection.

I. Cohen, M. Fridkin, M. Fridkin, 1999, The Journal of infectious diseases.

Retracted Correction: CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

M. Eisenstein, O. Mandelboim, M. Fridkin, 1998, Nature.

Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity and mimic the three-dimensional structure of the binding-site of acetylcholine receptor.

E. Katchalski‐Katzir, J. Sussman, M. Harel, 2002, Biophysical chemistry.

Toxicology and Antitumor Activity of Tuftsin a

Z. Fuks, L. Weiss, R. Catane, 1983, Annals of the New York Academy of Sciences.

RECEPTORS FOR TUFTSIN ON PLASMA MEMBRANES OF MACROPHAGES AND MACROPHAGE HYBRIDOMA CELL LINES

S. Dagan, M. Fridkin, E. Tzehoval, 1987 .

Mechanisms controlling differentiation and function of antigen-presenting macrophages.

P. De Baetselier, S. Segal, M. Fridkin, 1982, Advances in experimental medicine and biology.

Anti-acetylcholine receptor response achieved by immunization with a synthetic peptide from the receptor sequence.

S. Fuchs, M. Fridkin, D. Neumann, 1984, Biochemical and biophysical research communications.

Hypothalamic hormones in milk.

M. Fridkin, Y. Koch, H. Werner, 1991, Endocrine Regulations.

Vasoactive intestinal peptide: a growth promoter in neuroblastoma cells.

I. Gozes, G. Lilling, M. Fridkin, 1993, Brain research.

VIP analogues inhibit small cell lung cancer growth

T. Moody, I. Gozes, J. Reubi, 1992 .

Synthesis and bioactivity of fatty acid-conjugated GnRH derivatives.

M. Fridkin, Y. Koch, N. Ben-Aroya, 1999, Life sciences.

Degradation of C-reactive protein (CRP) by neutrophil lysosomal enzymes generates peptidic neutrophil modulators

M. Fridkin, F. Beer, E. Shephard, 1991 .

Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period.

Gideon Schreiber, G. Schreiber, Y. Shechter, 2004, Journal of medicinal chemistry.

Protection against developmental and learning impairments in apolipoprotein e-deficient mice by activity-dependent femtomolar-acting peptides

I. Gozes, A. Bardea, D. Brenneman, 1997, Neuroscience Letters.

N-[(2-Sulfo)-9-fluorenylmethoxycarbonyl](3)-gentamicin C(1) is a long-acting prodrug derivative.

Y. Shechter, M. Fridkin, H. Tsubery, 2002, Journal of medicinal chemistry.

Helminth-Based Product and the Microbiome of Mice with Lupus

I. Barshack, O. Koren, Y. Shoenfeld, 2019, mSystems.

Authors' Reply

H. Werner, D. Chan, K. Cheah, 2009 .

The 2,4-dinitrophenyl group for protection of hydroxyl function of tyrosine during solid-phase peptide synthesis.

M. Fridkin, I. Pecht, R. Philosof-Oppenheimer, 2009, International journal of peptide and protein research.

Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006

Leslie G. Ungerleider, D. Amit, H. Seung, 2006, Neural Plasticity.

Design and synthesis of peptides that bind alpha-bungarotoxin with high affinity.

E. Katchalski‐Katzir, M. Balass, S. Fuchs, 2001, Chemistry & biology.

The Design, Synthesis, and Biological Evaluation of VIP and VIP Analogs

I. Gozes, M. Fridkin, D. Dangoor, 2008 .

Inhibition of human leukocyte elastase and cathepsin G by extended peptides and subunits derived from human C-reactive protein

M. Pontet, D. Desiderio, M. Fridkin, 2004, Letters in peptide science.

INFLUENCE OF THE SYNTHETIC PENTAPEPTIDE LAsp‐Ser‐Asp‐Pro‐Arg ON THE DIRECT AND INDIRECT MAST CELL DEGRANULATION INDUCED BY REAGINIC ANTIBODIES

M. Fridkin, Z. Spirer, N. Vardinon, 1977, Acta allergologica.

Growth hormone releasing factor-like immunoreactivity in human milk.

M. Fridkin, Y. Koch, H. Werner, 1986, Biochemical and biophysical research communications.

The use of polymeric carriers in the synthesis of cyclic peptides containing s s bonds abstract

M. Fridkin, A. Patchornik, E. Bondi, 1968 .

Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions.

A. Horovitz, Y. Shechter, M. Walker, 2019, Toxicology and applied pharmacology.

Design, synthesis, and evaluation of a long-acting, potent analogue of gonadotropin-releasing hormone.

M. Fridkin, Y. Koch, S. Rahimipour, 2001, Journal of medicinal chemistry.

Design and synthesis of potent hexapeptide and heptapeptide gonadotropin-releasing hormone antagonists by truncation of a decapeptide analogue sequence.

M. Fridkin, Y. Koch, S. Rahimipour, 2000, Journal of medicinal chemistry.

Vanadate restores glucose 6-phosphate in diabetic rats: a mechanism to enhance glucose metabolism.

Y. Shechter, I. Goldwaser, M. Fridkin, 2000, American journal of physiology. Endocrinology and metabolism.

A Fatty Neuropeptide: Potential Drug for Noninvasive Impotence Treatment in a Rat Model

I. Gozes, M. Fridkin, 1993 .

A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice.

E. Mozes, M. Fridkin, N. Brosh, 2000, Immunology Letters.

Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide.

Y. Schwarz, Y. Shechter, Y. Vachutinsky, 2008, Bioconjugate chemistry.

On the Synthesis of Naphthoquinonyl Heterocyclic Amino Acids

M. Fridkin, S. Rahimipour, P. B. Shrestha‐Dawadi, 1996 .

Delivery of neuropeptides from the periphery to the brain: studies with enkephalin.

Y. Shechter, E. Heldman, M. Fridkin, 2010, ACS chemical neuroscience.

Synthesis of Naphthoquinonyl Heterocylic Amino Acids.

M. Fridkin, S. Rahimipour, P. B. Shrestha‐Dawadi, 1997 .

E. Muñoz-Elías, I. Gozes, M. Delgado, 1998, The Journal of Biological Chemistry.

Lipophilic vasoactive intestinal peptide: Potential drug for non-invasive impotence treatment

I. Gozes, M. Fridkin, 1993 .

Enzymatic processing of serum proteins: A route to peptides associated with host defense

M. Pras, M. Fridkin, E. Tzehoval, 1993 .

Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in an in Vitro Model of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins*

Y. Shechter, M. Schnaider-Beeri, M. Fridkin, 2012, Journal of Biological Chemistry.

C-reactive protein (CRP) peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation.

R. Anderson, M. Fridkin, E. Shephard, 1992, Immunology.